Sucampo Pharmaceuticals Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 139

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

  • Investments
  • 5

Sucampo Pharmaceuticals General Information

Description

Manufacturer and developer of specialized medicines. The company focuses on the development and commercialization of drugs based on prostones a class of compounds derived from functional fatty acids that occur naturally in the human body that are used for the treatment of chronic and idiopathic constipation, irritable bowel syndrome with constipation and opioid-induced constipation, enabling adult patients to live their lives better.

Contact Information

Website
www.sucampo.com
Formerly Known As
R-Tech Ueno (USA)
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 805 King Farm Boulevard
  • Suite 550
  • Rockville, MD 20850
  • United States
+1 (301)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • 805 King Farm Boulevard
  • Suite 550
  • Rockville, MD 20850
  • United States
+1 (301)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sucampo Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sucampo Pharmaceuticals‘s full profile, request access.

Request a free trial

Sucampo Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer and developer of specialized medicines. The company focuses on the development and commercialization of dru
Pharmaceuticals
Rockville, MD
139 As of 2016

Foster City, CA
 

Stockholm, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sucampo Pharmaceuticals Competitors (50)

One of Sucampo Pharmaceuticals’s 50 competitors is Gilead, a Formerly VC-backed company based in Foster City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gilead Formerly VC-backed Foster City, CA
Swedish Orphan Biovitrum Formerly VC-backed Stockholm, Sweden
Merck & Co. Corporation Rahway, NJ
Incyte Formerly VC-backed Wilmington, DE
Bristol-Myers Squibb Corporation Princeton, NJ
You’re viewing 5 of 50 competitors. Get the full list »

Sucampo Pharmaceuticals Patents

Sucampo Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2004062669-A1 Use of a macrolide compound for treating dry eye Inactive 16-Jan-2003
US-20040198763-A1 Usign tacrolimus; eye drops Inactive 16-Jan-2003
JP-2011012071-A Pharmaceutical composition containing fk506 derivative for treating allergic disease, and use thereof Pending 09-Aug-2002
AU-2003256068-A1 Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases Inactive 09-Aug-2002
EP-1536793-A1 Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases Inactive 09-Aug-2002 A61K31/4745
To view Sucampo Pharmaceuticals’s complete patent history, request access »

Sucampo Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sucampo Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sucampo Pharmaceuticals‘s full profile, request access.

Request a free trial

Sucampo Pharmaceuticals Investments & Acquisitions (5)

Sucampo Pharmaceuticals’s most recent deal was a Later Stage VC with Cancer Prevention Pharmaceuticals for . The deal was made on 14-Sep-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cancer Prevention Pharmaceuticals 14-Sep-2017 Later Stage VC Drug Discovery
Vtesse 03-Apr-2017 Merger/Acquisition Drug Discovery
R-Tech Ueno 22-Oct-2015 PIPE Drug Delivery
R-Tech Ueno 13-Oct-2015 Merger/Acquisition Drug Delivery
Sucampo 29-Dec-2010 Merger/Acquisition Drug Discovery
To view Sucampo Pharmaceuticals’s complete investments and acquisitions history, request access »

Sucampo Pharmaceuticals Exits (1)

Sucampo Pharmaceuticals’s most recent exit was on 14-Sep-2017 from Cancer Prevention Pharmaceuticals. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Cancer Prevention Pharmaceuticals 14-Sep-2017 Completed
  • 2 buyers
To view Sucampo Pharmaceuticals’s complete exits history, request access »

Sucampo Pharmaceuticals FAQs

  • When was Sucampo Pharmaceuticals founded?

    Sucampo Pharmaceuticals was founded in 1996.

  • Where is Sucampo Pharmaceuticals headquartered?

    Sucampo Pharmaceuticals is headquartered in Rockville, MD.

  • What is the size of Sucampo Pharmaceuticals?

    Sucampo Pharmaceuticals has 139 total employees.

  • What industry is Sucampo Pharmaceuticals in?

    Sucampo Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Sucampo Pharmaceuticals a private or public company?

    Sucampo Pharmaceuticals is a Private company.

  • What is the current valuation of Sucampo Pharmaceuticals?

    The current valuation of Sucampo Pharmaceuticals is .

  • What is Sucampo Pharmaceuticals’s current revenue?

    The current revenue for Sucampo Pharmaceuticals is .

  • How much funding has Sucampo Pharmaceuticals raised over time?

    Sucampo Pharmaceuticals has raised $306M.

  • Who are Sucampo Pharmaceuticals’s investors?

    Astellas Pharma, Athyrium Capital Management, MCP Capital, Mitsubishi UFJ Capital, and Nissay Capital are 5 of 9 investors who have invested in Sucampo Pharmaceuticals.

  • Who are Sucampo Pharmaceuticals’s competitors?

    Gilead, Swedish Orphan Biovitrum, Merck & Co., Incyte, and Bristol-Myers Squibb are some of the 50 competitors of Sucampo Pharmaceuticals.

  • When was Sucampo Pharmaceuticals acquired?

    Sucampo Pharmaceuticals was acquired on 01-Feb-2018.

  • Who acquired Sucampo Pharmaceuticals?

    Sucampo Pharmaceuticals was acquired by Mallinckrodt Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process